New Times,
New Thinking.

  1. Culture
13 October 2010

Howard Jacobson wins the Man Booker Prize

Recognition at last for the author of The Finkler Question.

By Jonathan Derbyshire

Leo Robson concluded his survey of the Man Booker Prize shortlist with this prediction: “I think the prize will be given to [Howard] Jacobson or [Emma] Donoghue.” He was right. Jacobson won last night with his novel The Finkler Question, a book that Robson mildly disparaged in his review of it for the NS back in July:

[Jacobson’s] new novel, though by no means a negligible work, discomforts the reader with uncertain descriptions, callous sarcasms and failed gags. Strange turns are likely, perhaps inevitable, in the career of any hard-working novelist but rarely do they defy explanation.

Robson thought The Finkler Question compared unfavourably with Jacobson’s 2006 novel, Kalooki Nights, “a torrential comedy of ideas and impressions set in Manchester in the 1950s and London in the present day, concerned with the psychic and psychosexual effect of the pogroms and death camps on English Jews and constructed from passages of exact and agile prose”.

Some of those present at the awards dinner wondered if the Booker judges were compensating Jacobson for previous near-misses as much as they were recognising The Finkler Question. But two members of the judging panel strenuously denied this was the case when I put it to them.

Select and enter your email address Your weekly guide to the best writing on ideas, politics, books and culture every Saturday. The best way to sign up for The Saturday Read is via saturdayread.substack.com The New Statesman's quick and essential guide to the news and politics of the day. The best way to sign up for Morning Call is via morningcall.substack.com
Visit our privacy Policy for more information about our services, how Progressive Media Investments may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications.
THANK YOU

Content from our partners
Unlocking investment in UK life sciences through manufacturing
Data defines a new era for fundraising
A prescription for success: improving the UK's access to new medicines